hirly

Parallel Bio

Member of Technical Staff, Full-Stack AI Engineer/Researcher (Staff+ Level)

San Francisco, CA

hirly Pro

Get in front of the people hiring at Parallel Bio

  • Reach the hiring manager at Parallel Bio on LinkedIn, from your own account
  • hirly applies to this job for you, with unlimited applications
  • A resume and cover letter written for this job, unlimited
  • The hiring manager and recruiter at Parallel Bio, with contact details
Get Pro for this job →

$49 a month · ₹1,999 for 30 days in India · cancel any time

See how you match this job — and similar ones. Free.

Upload your resume and hirly scores it against this role at Parallel Bio first, then against similar open jobs, and shows where you fit and why.

PDF or DOCX, up to 12MB. No sign-up to see your matches.

Get past the screening software and onto a recruiter's desk

hirly rewrites your resume for this job — matching the keywords and skills in the posting, moving your most relevant experience to the top, and writing a cover letter to fit. About 30 seconds.

  • Keywords matched to this posting
  • Fit score before you apply
  • Cover letter included

Matched against 2.2M live jobs from 220,000+ employers in 200+ countries.

Tailor my resume for this job →

Apply from your AI assistant

Connect hirly to Claude or ChatGPT and ask it to apply to this job. hirly tailors your resume, fills the employer’s form and asks before sending.

Some employer sites stop an application at a CAPTCHA or sign-in and hand it back with a link. Applying needs a paid plan. Works with any assistant that supports MCP.

hirly's read of this role

Role family
Engineering
Seniority
Lead / management
Country
US
Work mode
On-site / unstated
First seen by hirly
18 Nov 2026

Derived automatically from the posting. Upload your resume above to see how the role scores against it.

the posting

The Mission

More than 95% of drugs that pass animal testing fail in human trials. A single new drug takes about $2.6 billion and 12.5 years to develop, and most of that effort goes to candidates that were never going to work in people.

AI was supposed to change this. But most AI for drug discovery is still trained on the same inputs that got us here: animal data, irreproducible papers, and cell lines that don’t respond like living tissue. A model can only learn the biology it’s shown, and no amount of scale or compute fixes bad data.

What’s missing is data on how living human tissue responds to a drug, across the range of people who will actually take it. That data barely exists, because there has been no way to generate it at scale without putting patients at risk.

Parallel Bio grows it. Our expert biologists build living human immune systems, called immune organoids, from a proprietary biobank spanning ages, sexes, ancestries and disease states. That means we can ask how a drug behaves in an older patient, a specific ancestry or an autoimmune background, not just in an average donor. We've already modeled immunotoxicology, immunogen stimulation and two autoimmune diseases, with more on the way. Our founders are world experts in scalable organoids. Robert is a Stanford-trained immunologist. Juliana trained in the lab that invented the first organoid and later automated them at System1 Biosciences.

We run these experiments in an AI-driven robotic lab, and every experiment makes our world model smarter, which in turn chooses better experiments. We build every layer ourselves: the biology, the robotics, the data infrastructure, and the model that orchestrates it all. The whole lab is callable over API and MCP, so AI agents can design and run real biological experiments, within safety limits we set. For biologists, that means asking questions at a scale and pace no bench can match. For engineers, it means building AI that learns from real human biology instead of the literature.

It's already working. Our platform is 87% concordant with clinical outcomes, compared with roughly 3% translational success for animal models. Five Fortune 500 companies use it to test drugs, and our data has informed a Phase 1 trial. We've raised ~$30M from AIX Ventures, Marc Benioff, Jeff Dean and Y Combinator. With the FDA Modernization Act 3.0 and the FDA's March 2026 validation framework, regulation is moving our way.

The opportunity is generational. We're building the first scaled engine for real human biological data, and using it to know which drugs will work in people before they ever reach a trial.

Your Skills

Must be able to operate across the entire AI stack: evals, agentic harnesses, and models

Parallel Bio is an equal opportunity employer committed to fostering an inclusive and respectful workplace. We encourage applications from individuals of all backgrounds, regardless of age, gender, ethnicity, religion, disability, or sexual orientation.

Original posting on Parallel Bio's site ↗

Listed on hirly, a job board. hirly is not the employer: Parallel Bio is hiring for this role.

Browse similar roles

Want this one?

Upload your resume and hirly rewrites it for this job and writes the cover letter — in about thirty seconds, before you sign up.

Tailor my resume for this job